HQ: San Diego, CA, USACEO: Jacob ThaysenHeadcount: 8000+illumina.com ↗
Funding Summary
Total Funding
N/A (public since 2000)
Latest Valuation
~$20B (public market cap)
About
The dominant DNA sequencing company, providing the foundational read technology that underpins virtually all synthetic biology workflows. Illumina sequencers are used for QC, verification, and discovery across the entire synbio ecosystem.
Products
novaseq-xmiseqnextseq
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →